Dengue Mathematical Model
Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Original Source

https://sam.gov/workspace/contract/opp/4e18984fe5b2446a8a1db3a7882d9f8e/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a specialized mathematical model focused on dengue research. This procurement aims to enhance understanding and management of dengue through advanced research and development in the physical, engineering, and life sciences. The selected contractor will be responsible for delivering a comprehensive model that supports health-related research and applied studies, which are critical for public health initiatives. Interested parties can reach out to Joshua Dean at joshua.r.dean2.civ@health.mil or Patrick Harris at patrick.k.harris11.civ@health.mil for further details regarding this opportunity.

    Lifecycle
    Title
    Type
    Dengue Mathematical Model
    Currently viewing
    Special Notice
    Similar Opportunities
    FlowJo Software License Renewals
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the renewal of 25 FlowJo Software Licenses for the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The procurement requires licenses that support flow cytometric data analysis, accept FCS files from BD and Beckman Coulter cytometers, and provide features such as usage reports and simultaneous user access, among others. This opportunity is a total small business set-aside, with a firm fixed price (FFP) structure, and quotes are due by January 5, 2026, following a release on December 12, 2025. Interested vendors should direct inquiries to Jayme Fletcher or Emily K. O'Hara via their provided email addresses.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    Redacted J&A
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking professional support services as outlined in the Justification and Approval (J&A) document. The procurement aims to fulfill specific requirements related to health services, although detailed objectives are provided in the attached FAR Part 6 J&A document. These services are critical for maintaining the operational effectiveness of health programs within the military context. Interested parties can reach out to Jaclyn Svincek at jaclyn.p.svincek.civ@health.mil or Jennifer C. Jackson at jennifer.c.jackson18.civ@health.mil for further information, with the performance expected to take place in Silver Spring, MD.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is conducting market research for the development of a barrier combination product aimed at preventing and treating battlefield wounds and subsequent infections. This initiative, part of the Battlefield Wound Infection Prevention and Treatment (BWI P&T) program, seeks to identify commercial solutions that can effectively address the unique challenges of wound care in austere environments, where medical resources may be limited. The barrier combination product is expected to play a crucial role in a Family of Systems (FoS) approach, providing innovative solutions for both military and commercial applications in wound care. Interested parties are invited to submit their responses by January 20, 2026, at 2:00 PM Eastern, via email to the primary contacts, Jeanette Collins and Julie Burns, whose emails are provided in the opportunity overview. This RFI is for planning purposes only, and no contract will be awarded based on the responses received.
    Air Force Weapons Research, Development and Test
    Dept Of Defense
    The Department of Defense, specifically the Department of the Air Force, is seeking to award a contract for the Air Force Weapons Research, Development, and Test initiative. This procurement aims to engage the Johns Hopkins University Applied Physics Laboratory (JHU/APL) to conduct fundamental, applied, and advanced research that will facilitate the development of both kinetic and non-kinetic weapon technologies. The research is critical for enhancing national defense capabilities and ensuring the advancement of military technologies. Interested parties can reach out to primary contact Jace Hilton at jace.hilton@us.af.mil or secondary contact Vincent Pitts at vincent.pitts@us.af.mil for further information regarding this opportunity.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
    Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army, is seeking collaboration with qualified entities for the Generative Unconstrained Intelligence Drug Engineering (GUIDE) program, aimed at accelerating the development of medical countermeasures for warfighters. This initiative involves an integrated computational and experimental platform that leverages advanced simulation and machine learning to enhance the discovery and design of biological products and small molecule drugs, ensuring safety, efficacy, and manufacturability. The GUIDE program is critical for improving preparedness against diverse threats and is executed under a Participant Basic Agreement (PBA), with interested parties encouraged to demonstrate their technical relevance by contacting the primary points of contact, Joseph McCaffery and Keith Pereira, via email. Participation is contingent upon registration in the System for Award Management (SAM) database, and the government emphasizes that this announcement is for planning purposes only, with no commitment to award contracts at this stage.
    MTEC-26-01-BloodBag Request for Project Proposals Pre-Announcement
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for the manufacturing of single blood donor collection and storage bags within the Continental United States (CONUS). This initiative aims to address the critical shortage of blood storage bags, particularly for use in forward military operations, by establishing domestic manufacturing capabilities to ensure rapid production in times of need. The selected proposals will focus on producing blood bags that meet specific FDA and military standards, with an expected funding availability of up to $4 million for initial awards ranging from $1 to $3 million, and a performance period not exceeding 42 months. Interested parties should contact Dr. Chuck Hutti at chuck.hutti@ati.org for further inquiries and must be members of the Medical Technology Enterprise Consortium (MTEC) to submit proposals, which are anticipated to be released shortly.
    Notice of Intent Research Swine
    Dept Of Defense
    The Defense Health Agency (DHA) is issuing a Notice of Intent to procure research swine through a Sole Source negotiation with Midwest Research Swine, LLC. The procurement involves the supply of High Health Status Yorkshire-cross and Duroc research swine, which are critical for the United States Army Institute of Surgical Research's ongoing research efforts. This opportunity follows a previous award and is not open for competitive quotations; however, interested parties may submit capability information by December 18, 2025, to determine the potential for competitive procurement. For inquiries, contact Andy Shortall at william.a.shortall.civ@health.mil or call 301-619-2212.